Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 70518-4051

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 70518-4051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This text provides information about Quetiapine, an extended-release tablet in 150 mg strength. It includes details such as NDC number, manufacturer (ScieGen Pharmaceuticals, Inc.), dosage instructions, quantity (30 tablets), and storage instructions. Additionally, it mentions not to split, crush, or chew the tablet and advises keeping the medication out of reach of children. The text also indicates the repackager as RemedyRepack Inc., located in Indiana, PA.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

FDA Label Image

Structural Formula (Quetiapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.